On-treatment derived neutrophil-to-lymphocyte ratio and response to palbociclib and letrozole: Analysis of a multicenter retrospective cohort and the PALOMA-2 study.

Chang Gon Kim,Min Hwan Kim,Jee Hung Kim,Seul-gi Kim,Gun Min Kim,Tae Yeong Kim,Won Ji Ryu,Jee Ye Kim,Hyung Seok Park,Seho Park,Youngup Cho,Byeong-Woo Park,Seung Il Kim,Joon Jeong,Joohyuk Sohn

On-treatment derived neutrophil-to-lymphocyte ratio and response to palbociclib and letrozole: Analysis of a multicenter retrospective cohort and the PALOMA-2 study.

2021

Chang Gon Kim
Min Hwan Kim
Jee Hung Kim
Seul-gi Kim
Gun Min Kim
Tae Yeong Kim
Won Ji Ryu
Jee Ye Kim
Hyung Seok Park
Seho Park
Youngup Cho
Byeong-Woo Park
Seung Il Kim
Joon Jeong
Joohyuk Sohn

1066Background: Relevant predictive biomarkers for cyclin dependent kinase 4 and 6 (CDK4/6) inhibitors have not been identified in hormone receptor (HR)-positive, human epidermal growth factor rece...

Keywords:

Letrozole
Retrospective cohort study
Oncology
Internal medicine
predictive biomarker
Medicine
Cyclin-dependent kinase 4
Palbociclib
Neutrophil to lymphocyte ratio
Human epidermal growth factor
Hormone receptor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations